← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

▼ SELL 10b5-1 Plan

$ Value

$1.1M

Shares

40,000

Price

$28

Filed

Nov 18

Insider

Name

Bush Tia L

Title

Chief Technology & Quality Ofc

CIK

0001863418

Roles

Officer

Transaction Details

Transaction Date

2025-11-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

121,503

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024. | 25% of the shares subject to such option shall vest and become exercisable on May 20, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.

Filing Info

Accession No.

0001470831-25-000343

Form Type

4

Issuer CIK

0001847903

Bush Tia L's History

Date Ticker Type Value
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-01 CNTA F $210K
2025-11-17 CNTA M $377K
2025-11-17 CNTA $1.1M
2025-11-17 CNTA M $0
2025-11-12 CNTA M $377K
2025-11-12 CNTA $1.0M
2025-11-12 CNTA M $0
2025-09-24 CNTA M $330K

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02